Quick Nav
Blogs

The Reinvented Pharmacist

DEA's Crackdown on Pain Medication Abuse: Out of Step

Monday, February 6th, 2012
USA Today reports that the Drug Enforcement Administration (DEA) “have expanded their crackdown on painkiller abuse, charging a major health care company and two CVS pharmacies in Florida with violating their licenses to sell powerful pain ‘medications’ and other drugs.” The agency “linked Cardinal Health to unusually high shipments of the controlled drugs to four pharmacies. On Friday, the DEA suspended Cardinal’s controlled substances license at its Lakeland, Fla., distribution center, which services 2500 pharmacies in Florida, Georgia and South Carolina.”
 
For some time, I have been wondering if the DEA, in its current focus, is an agency out of step with the needs we have today. Although I personally have not reached the point where we need to decriminalize the use of controlled substances, I do feel that we shouldn’t expect legitimate licensed agencies like drug wholesalers to be expected to accomplish what law enforcement agencies are not able to do.
 
I have spoken to some executives of pharmaceutical wholesalers who feel that the DEA expectations are impossible to meet. It seems to me that we end up putting controls on the legitimate elements in health care while the offenders keep doing wrong. 
 
To me, another example of the way the DEA is out of step is in how they have been so slow in developing mechanisms to use e-prescribing with controlled substances. They have certainly not demonstrated any leadership in this arena. 
 
I applaud Cardinal Health for taking the DEA on, not because we don’t want to get Pain Clinic prescription mills closed down—but because we don’t want to do it at the expense of legitimate providers who are truly meeting patient needs.
 
What do you think about the role DEA is now playing in health care? 
  
 
Blog Info
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times
Blog Description
This blog focuses on what our Editor-in-Chief sees as the future of pharmacy.
Author Bio
Fred Eckel, RPh, MS, is the Editor-in-Chief of Pharmacy Times, a position he has held since 2002. Mr. Eckel is a professor at the Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. He serves as executive director of the North Carolina Association of Pharmacists.

In this blog, Eckel will provide commentary on relevant issues impacting pharmacists and pharmacy professionals, including the merging of pharmacy benefit managers, the implications of health care reform, the conversion of major drugs from prescription to over-the-counter, trends in pharmacy careers, and opioid abuse. He will also discuss legislative issues that impact pharmacists, and comment on the evolving role of the pharmacist.
Blog Archive
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.
 




Become a Member
Forgot Password?